BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,438 | -31.2% | 2,450 | -16.9% | 0.04% | -26.7% |
| Q2 2023 | $134,402 | +12.3% | 2,950 | 0.0% | 0.06% | +7.1% |
| Q1 2023 | $119,652 | -20.4% | 2,950 | 0.0% | 0.06% | -20.0% |
| Q4 2022 | $150,361 | -5.4% | 2,950 | 0.0% | 0.07% | -14.6% |
| Q3 2022 | $159,000 | -18.5% | 2,950 | -3.3% | 0.08% | -10.9% |
| Q2 2022 | $195,000 | -17.4% | 3,050 | 0.0% | 0.09% | -9.8% |
| Q1 2022 | $236,000 | -47.2% | 3,050 | -41.4% | 0.10% | -41.4% |
| Q4 2021 | $447,000 | -42.6% | 5,205 | -46.2% | 0.17% | -47.1% |
| Q3 2021 | $779,000 | -18.9% | 9,680 | -18.9% | 0.33% | -18.4% |
| Q2 2021 | $961,000 | -8.4% | 11,935 | -4.0% | 0.40% | -11.6% |
| Q1 2021 | $1,049,000 | +2.4% | 12,435 | -2.5% | 0.46% | -3.2% |
| Q4 2020 | $1,024,000 | -0.2% | 12,755 | 0.0% | 0.47% | -8.9% |
| Q3 2020 | $1,026,000 | -6.6% | 12,755 | 0.0% | 0.52% | -10.6% |
| Q2 2020 | $1,098,000 | +4.0% | 12,755 | -1.9% | 0.58% | -6.9% |
| Q1 2020 | $1,056,000 | -2.9% | 13,000 | 0.0% | 0.62% | +21.1% |
| Q4 2019 | $1,087,000 | -4.4% | 13,000 | 0.0% | 0.51% | -9.8% |
| Q3 2019 | $1,137,000 | +6.8% | 13,000 | 0.0% | 0.57% | +5.4% |
| Q2 2019 | $1,065,000 | 0.0% | 13,000 | -0.8% | 0.54% | -0.9% |
| Q1 2019 | $1,065,000 | +23.5% | 13,100 | 0.0% | 0.54% | +11.2% |
| Q4 2018 | $862,000 | -14.7% | 13,100 | 0.0% | 0.49% | -3.9% |
| Q3 2018 | $1,010,000 | +4.4% | 13,100 | 0.0% | 0.51% | -5.7% |
| Q2 2018 | $967,000 | +12.7% | 13,100 | -0.8% | 0.54% | +10.2% |
| Q1 2018 | $858,000 | -6.5% | 13,200 | -7.0% | 0.49% | -2.2% |
| Q4 2017 | $918,000 | +3.0% | 14,200 | 0.0% | 0.50% | -0.8% |
| Q3 2017 | $891,000 | -0.6% | 14,200 | -4.1% | 0.51% | -3.6% |
| Q2 2017 | $896,000 | +16.7% | 14,800 | 0.0% | 0.52% | +14.6% |
| Q1 2017 | $768,000 | +7.3% | 14,800 | -6.5% | 0.46% | +3.6% |
| Q4 2016 | $716,000 | -4.8% | 15,837 | +0.2% | 0.44% | -5.6% |
| Q3 2016 | $752,000 | +5.0% | 15,800 | -0.2% | 0.47% | +5.9% |
| Q2 2016 | $716,000 | +10.0% | 15,837 | 0.0% | 0.44% | +7.8% |
| Q1 2016 | $651,000 | +11.3% | 15,837 | +3.3% | 0.41% | +6.2% |
| Q4 2015 | $585,000 | -5.3% | 15,337 | -18.6% | 0.39% | -12.3% |
| Q3 2015 | $618,000 | -50.4% | 18,837 | +5.6% | 0.44% | -47.2% |
| Q2 2015 | $1,247,000 | +29.8% | 17,837 | +27.1% | 0.83% | +31.3% |
| Q1 2015 | $961,000 | +13.2% | 14,037 | +21.1% | 0.64% | +14.6% |
| Q4 2014 | $849,000 | +24.1% | 11,587 | +21.5% | 0.55% | +19.9% |
| Q3 2014 | $684,000 | +12.1% | 9,537 | +13.0% | 0.46% | +19.4% |
| Q2 2014 | $610,000 | -0.7% | 8,437 | +1.2% | 0.39% | -15.1% |
| Q1 2014 | $614,000 | +9.8% | 8,337 | +3.7% | 0.46% | +23.6% |
| Q4 2013 | $559,000 | – | 8,037 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |